Tharimmune Inc. (THAR)
NASDAQ: THAR
· Real-Time Price · USD
1.33
0.01 (0.76%)
At close: Aug 15, 2025, 3:59 PM
1.32
-0.79%
After-hours: Aug 15, 2025, 07:30 PM EDT
Tharimmune Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -2.55M | -3.85M | -3.87M | -2.37M | -2.35M | -2.53M | -1.85M | -2.36M | -2.71M | -1.77M | -2.13M | -1.64M | -1.35M | -142.6K | -541.11K | -1.1M | -1.47M |
Interest Income | 13.44K | 27.67K | 72.73K | 53.61K | 95.89K | 57.73K | 28.45K | 34.2K | 32.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.54M | -3.82M | -3.8M | -2.33M | -2.26M | -2.47M | -1.82M | -2.34M | -2.69M | -1.77M | -2.13M | -1.64M | -2.94M | 2.45M | -853.44K | -1.56M | -2.25M |
Net Income | -2.54M | -3.82M | -3.8M | -2.33M | -2.26M | -2.47M | -1.82M | -2.34M | -2.69M | -1.77M | -2.13M | -1.64M | -2.94M | 2.45M | -853.44K | -1.56M | -2.25M |
Selling & General & Admin | 1.95M | 1.76M | 1.58M | 1.37M | 1.32M | 1.54M | 1.36M | 1.33M | 1.67M | 1.08M | 1.3M | 1.18M | 1.04M | 142.6K | 227.98K | 422.95K | 571.68K |
Research & Development | 594.07K | 2.09M | 2.28M | 999.55K | 1.03M | 992.73K | 488.18K | 1.03M | 1.05M | 683.21K | 831.84K | 455.55K | 307.83K | n/a | 313.13K | 674.76K | 895.91K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.55M | 3.85M | 3.87M | 2.37M | 2.35M | 2.53M | 1.85M | 2.36M | 2.71M | 1.77M | 2.13M | 1.64M | 1.35M | 142.6K | 541.11K | 1.1M | 1.47M |
Interest Expense | -8.47K | 758.00 | 3.01K | 5.22K | 4.7K | 354.00 | 3.5K | 6.52K | 6.14K | n/a | n/a | n/a | 1.59M | 258.37K | 235.82K | 188.9K | 148.19K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 3.85M | 3.87M | 2.37M | 2.35M | 2.53M | 1.85M | 2.36M | 2.71M | 1.77M | 2.13M | 1.64M | 1.35M | 142.6K | 541.11K | 1.1M | 1.47M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 13.92K | n/a | n/a | -9.34K | n/a | n/a | n/a | n/a | -71.39K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.57M | 1.97M | 1.55M | 962.15K | 783.85K | 782.64K | 46.12K | 39.87K | 30.7K | 30.7K | 30.75K | 30.86K | 28.2K | 30.3K | 27.45K | 27.45K | 29.95K |
Shares Outstanding (Diluted) | 2.57M | 1.97M | 1.55M | 962.15K | 783.85K | 782.64K | 46.12K | 39.87K | 30.7K | 30.7K | 30.75K | 30.86K | 28.2K | 30.3K | 27.45K | 27.45K | 29.95K |
EPS (Basic) | -0.99 | -2.95 | -2.45 | -2.42 | -2.88 | -3.16 | -39.47 | -58.62 | -87.55 | -57.53 | -69.18 | -53.04 | -104.35 | 80.94 | -31.09 | -56.68 | -75.12 |
EPS (Diluted) | -0.99 | -2.95 | -2.45 | -2.42 | -2.88 | -3.16 | -39.47 | -58.62 | -87.55 | -57.53 | -69.18 | -53.04 | -104.35 | 80.94 | -31.09 | -56.68 | -75.12 |
EBITDA | -2.55M | -3.82M | -3.79M | -2.32M | -2.25M | -2.47M | -1.82M | -2.33M | -2.68M | -1.77M | -2.13M | -1.64M | -1.35M | 2.67M | -541.11K | -1.37M | -2.1M |
EBIT | n/a | -3.82M | -3.79M | -2.32M | -2.25M | -2.47M | -1.82M | -2.33M | -2.68M | -1.77M | -2.13M | -1.64M | -1.35M | 2.71M | -617.61K | -1.37M | -2.1M |
Depreciation & Amortization | n/a | n/a | 72.73K | n/a | 43.28K | 43.81K | -39.59K | 122.08K | 41.58K | 54.88K | 27.08K | 86.06K | 60.46K | 71.39K | 54K | 55.81K | -634.27K |